Clinical Trials on Canalicular Obstruction in United Kingdom

Total 4450 results

The Cleveland Clinic

Completed

Lacrimal Drainage Resistance Study (LDRS)

Epiphora | Ectropion | Nasolacrimal Duct Obstruction | Canalicular Stenosis | Functional Tear Pump Failure

United States
Northumbria Healthcare NHS Foundation Trust
Newcastle-upon-Tyne Hospitals NHS Trust; National Institute for Health Research... and other collaborators

Completed

Mortality and Symptom Burden Post Hospitalisation With COPD (MoSHCOPD)

Pulmonary Disease, Chronic Obstructive | Emphysema | Chronic Bronchitis | Pulmonary Disease, Obstructive | Chronic Bronchitis With Airways Obstruction | Chronic Bronchitis With Acute Exacerbation

United Kingdom
Movetis

Completed

Efficacy Study of Prucalopride to Treat Chronic Intestinal Pseudo-Obstruction (CIP)

Chronic Intestinal Pseudo-Obstruction

United Kingdom
University of Nottingham
Northern Care Alliance NHS Foundation Trust; Cambridge University Hospitals... and other collaborators

Recruiting

Pseudo-obstruction Assessment With MRI (POM)

Chronic Intestinal Pseudo-Obstruction

United Kingdom
Imperial College London

Unknown

Physiology and Structure of the Small Airways in Patients With Chronic Airflow Obstruction or COVID-19 (PASSPORT)

COVID-19 | Asthma | Copd | Small Airways Disease

United Kingdom
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield

Recruiting

Development of a Patient Reported Outcome Measure for GastroIntestinal Recovery (PRO-diGI)

Ileus | Small Bowel Obstruction | Intestinal Failure

United Kingdom
Liverpool University Hospitals NHS Foundation Trust

Recruiting

Headgear Accessory for Exercise-Induced Laryngeal Obstruction Studies (HALOS)

Exercise-Induced Laryngeal Obstruction

United Kingdom
University Hospitals Dorset NHS Foundation Trust
The Christie NHS Foundation Trust

Recruiting

The ID- RFA Trial: A Trial of Intraductal Radio-frequency Ablation (ID-RFA) Plus Biliary Stenting Versus Biliary Stenting Alone for the Treatment of Malignant Biliary Obstruction.

Malignant Biliary Obstruction

United Kingdom
AstraZeneca

Completed

Study to Investigate Safety, Tolerability and Effect of Multiple Dosing With AZD 4721 and/or With AZD 5069

Chronic Obstructive Pulmonary Disease (COPD).

United Kingdom
King's College Hospital NHS Trust
University of Brighton

Completed

The Effects of a Home Exercise Video Programme for Patients With COPD

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Imperial College Healthcare NHS Trust
National Institute for Health Research, United Kingdom

Terminated

The Role of Ambulatory Oxygen in Improving the Effectiveness of Pulmonary Rehabilitation for COPD Patients

Chronic Obstructive Pulmonary Diseases

United Kingdom
University College, London
University of Cambridge; National Institute for Health Research, United Kingdom and other collaborators

Unknown

Development of an Optimal Antibiotic Regime for Long-term Therapy in Stable Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD).

United Kingdom
University of Lincoln
National Health Service, United Kingdom; Sanandco Ltd

Active, not recruiting

Use of MonitorMe in COPD

Chronic Obstructive Pulmonary Disease

United Kingdom
Imperial College London
AstraZeneca

Withdrawn

GR Defect in Peripheral Blood Mononuclear Cells in COPD

Chronic Obstructive Pulmonary Disease

United Kingdom
University of Edinburgh
Philips Healthcare

Completed

Physical Activity Enhancing Programme in COPD (PAEP)

Chronic Obstructive Pulmonary Disease

United Kingdom
University of Glasgow
NHS Research and Development

Completed

An Evaluation of Web Based Pulmonary Rehabilitation (webbasedPR)

Chronic Obstructive Pulmonary Disease

United Kingdom
Novartis Pharmaceuticals

Completed

Study of the Impact of Indacaterol (Onbrez®) on the Individual Lives and Health Status of Patients With COPD (INHALE)

Chronic Obstructive Pulmonary Disease

United Kingdom
AstraZeneca

Terminated

Effect of Roflumilast at Acute Exacerbations of Chronic Obstructive Pulmonary Disease (TREAT)

Chronic Obstructive Pulmonary Disease With (Acute) Exacerbation

United Kingdom
Imperial College London

Completed

NO Donors and Inhibitors to Study Imbalance of Nitrogen Stress and Antioxidant Defense in COPD

Chronic Obstructive Pulmonary Disease

United Kingdom
Verona Pharma plc

Completed

The Effects of RPL554 on Top of Standard COPD Reliever Medications

Chronic Obstructive Pulmonary Disease

United Kingdom
Pulmatrix Inc.
Quotient Bioresearch

Completed

Safety, Tolerability, and Pharmacodynamic Effect Study of PUR118

Chronic Obstructive Pulmonary Disease

United Kingdom
NHS Greater Glasgow and Clyde
Chief Scientist Office of the Scottish Government

Unknown

Glasgow Supported Self Management Trial (GSuST) (GSuST)

Chronic Obstructive Pulmonary Disease

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration (GLY2)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Cardiff University
GlaxoSmithKline; Cardiff Metropolitan University

Completed

Assessment of Risk in Chronic Airways Disease Evaluation (ARCADE)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Imperial College London
University of Nottingham; University College, London; University of Southampton; Queen's University, Belfast and other collaborators

Active, not recruiting

The BLF Early COPD Development Partnership Grant

Chronic Obstructive Pulmonary Disease

United Kingdom
University of Dundee
Tenovus Scotland

Completed

Beta Blocker Therapy in Moderate to Severe COPD (ANDA2)

Chronic Obstructive Pulmonary Disease

United Kingdom
AstraZeneca
Quintiles, Inc.

Completed

This Study Will Investigate How Food and Age Effect the Way the Body Handles the AZD5069 Drug Given as a Oral Dose

Chronic Obstructive Pulmonary Disease

United Kingdom
Imperial College London
National Institute for Health Research, United Kingdom

Completed

Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)

ASTHMA | CHRONIC OBSTRUCTIVE PULMONARY DISEASE | HEALTHY SUBJECTS

United Kingdom
Guy's and St Thomas' NHS Foundation Trust

Completed

The Role of HNHF to Improve Clinical Outcomes Following Severe AECOPD

Chronic Obstructive Pulmonary Disease

United Kingdom
Guy's and St Thomas' NHS Foundation Trust

Completed

NRD to Predict COPD Exacerbations at Home

Chronic Obstructive Pulmonary Disease

United Kingdom
Philips Respironics

Completed

Evaluating Forced Oscillation Technique (FOT) in Abolishing Flow Limitation

Chronic Obstructive Pulmonary Disease

United Kingdom
Patrick Murphy
Philips Respironics

Completed

Validation of the AVAPS AE Algorithm in Chronic Obstructive Pulmonary Disease (COPD) Patients (AVAPS-AE)

OSA | COPD

United Kingdom
GlaxoSmithKline
University of Cambridge

Completed

Effects Of Oral Prednisolone On Bone Metabolism In Patients With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

United Kingdom
my mhealth Ltd
Portsmouth Hospitals NHS Trust

Completed

Comparing Online Pulmonary Rehabilitation 'myPR' Versus Conventional Pulmonary Rehabilitation for Patients With COPD (TROOPeR)

Chronic Obstructive Pulmonary Diseases

United Kingdom
Imperial College London
AstraZeneca

Completed

Effect of Symbicort ® on GR in Sputum in COPD

Chronic Obstructive Lung Disease

United Kingdom
National Services for Health Improvement Ltd
GlaxoSmithKline

Completed

Characterisation of People With COPD (CoCO)

Chronic Obstructive Pulmonary Disease

United Kingdom
my mhealth Ltd
Portsmouth Hospitals NHS Trust

Completed

Trial of E-Health Platform Supported Care vs Usual Care After Exacerbation of COPD (RESCUE)

Chronic Obstructive Pulmonary Diseases

United Kingdom
Guy's and St Thomas' NHS Foundation Trust
Alung Technologies

Completed

ECCO2R as an Adjunct to NIV in AECOPD

Chronic Obstructive Pulmonary Disease

United Kingdom
University of Dundee

Completed

Chronic Beta-blockade and Cardiopulmonary Exercise in COPD (CPET1)

Chronic Obstructive Pulmonary Disease

United Kingdom
University of Nottingham

Completed

The Effect of Statins in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

United Kingdom
Barts & The London NHS Trust
National Health Service, United Kingdom

Completed

Trial of Vitamin D Supplementation in Chronic Obstructive Pulmonary Disease (ViDiCO)

Chronic Obstructive Pulmonary Disease

United Kingdom
AstraZeneca
Quintiles, Inc.

Terminated

A Study to Assess Safety, Tolerability and Pharmacokinetics of of AZD6553 in Healthy Volunteers and Patients With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

United Kingdom
AstraZeneca
Parexel; Covance; The Doctors Laboratory; Industrias Farmacéuticas Almirall S.A.

Completed

Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Male Japanese Subjects

Chronic Obstructive Pulmonary Disease - COPD

United Kingdom
Respivert Ltd

Completed

Safety, Tolerability and Pharmacokinetics (PK) of RV1162 in Healthy Subjects and COPD Patients

Healthy Volunteers | Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Pulmatrix Inc.

Completed

A Phase 1b Study of PUR1800 in Patients With COPD

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Imperial College London

Completed

Characteristics That Identify Exacerbation Risk Following Colds in COPD Patients

Chronic Obstructive Pulmonary Disease

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose in Healthy Volunteers, Repeat Doses in Asthmatic Patients and of Single Dose in COPD Patients of CHF6366

Chronic Obstructive Pulmonary Disease | Asthma

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

Safety and Tolerability of Inhaled CHF 6001 in Healthy Volunteers (HV)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
AstraZeneca

Completed

A First Time in Man Study to Asses the Safety and Tolerability of AZD7624 in Healthy Subjects

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

Evaluation of the Absolute Bioavailability and Mass Balance of CHF6001 (Tanimilast) in Healthy Subjects

Chronic Obstructive Pulmonary Disease (COPD) | COPD

United Kingdom

Clinical Trials on Canalicular Obstruction in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations